title: The feasibility of incorporating Vpx into lentiviral gene therapy vectors.
abstract: While current antiretroviral therapy has significantly improved, challenges still remain in life-long targeting of HIV-1 reservoirs. Lentiviral gene therapy has the potential to deliver protective genes into the HIV-1 reservoir. However, inefficient reverse transcription (RT) occurs in HIV-1 reservoirs during lentiviral gene delivery. The viral protein Vpx is capable of increasing lentiviral RT by antagonizing the restriction factor SAMHD1. Incorporating Vpx into lentiviral vectors could substantially increase gene delivery into the HIV-1 reservoir. The feasibility of this Vpx approach was tested in resting cell models utilizing macrophages and dendritic cells. Our results showed Vpx exposure led to increased permissiveness of cells over a period that exceeded 2 weeks. Consequently, significant lower potency of HIV-1 antiretrovirals inhibiting RT and integration was observed. When Vpx was incorporated with anti-HIV-1 genes inhibiting either pre-RT or post-RT stages of the viral life-cycle, transduction levels significantly increased. However, a stronger antiviral effect was only observed with constructs that inhibit pre-RT stages of the viral life cycle. In conclusion this study demonstrates a way to overcome the major delivery obstacle of gene delivery into HIV-1 reservoir cell types. Importantly, incorporating Vpx with pre-RT anti-HIV-1 genes, demonstrated the greatest protection against HIV-1 infection.
authors: The Kirby Institute, University of New South Wales , Sydney, Australia.
authors: Samantha A
authors: SA
authors: McAllery
authors: The Kirby Institute, University of New South Wales , Sydney, Australia.
authors: Chantelle L
authors: CL
authors: Ahlenstiel
authors: St Vincent's Center for Applied Medical Research , Darlinghurst, Australia.
authors: Kazuo
authors: K
authors: Suzuki
authors: St Vincent's Center for Applied Medical Research, Darlinghurst, Australia; Calimmune Pty Ltd., Darlinghurst, Australia.
authors: Geoff P
authors: GP
authors: Symonds
authors: The Kirby Institute, University of New South Wales, Sydney, Australia; St Vincent's Center for Applied Medical Research, Darlinghurst, Australia.
authors: Anthony D
authors: AD
authors: Kelleher
authors: The Kirby Institute, University of New South Wales , Sydney, Australia.
authors: Stuart G
authors: SG
authors: Turville